Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Accuray Inc (ARAY)

Accuray Inc (ARAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 125,676
  • Shares Outstanding, K 103,013
  • Annual Sales, $ 446,550 K
  • Annual Income, $ -15,550 K
  • EBIT $ 10 M
  • EBITDA $ 17 M
  • 60-Month Beta 1.30
  • Price/Sales 0.29
  • Price/Cash Flow N/A
  • Price/Book 2.59

Options Overview Details

View History
  • Implied Volatility 123.49% ( -21.16%)
  • Historical Volatility 75.96%
  • IV Percentile 59%
  • IV Rank 19.00%
  • IV High 583.80% on 11/26/24
  • IV Low 15.50% on 07/26/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 97
  • Volume Avg (30-Day) 57
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 7,060
  • Open Int (30-Day) 6,884

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.03
  • Number of Estimates 2
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year 0.03
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1401 +7.01%
on 06/06/25
1.7700 -31.07%
on 05/21/25
-0.4400 (-26.51%)
since 05/13/25
3-Month
1.1401 +7.01%
on 06/06/25
1.9300 -36.79%
on 03/25/25
-0.5200 (-29.89%)
since 03/13/25
52-Week
1.1401 +7.01%
on 06/06/25
2.9500 -58.64%
on 02/06/25
-0.5400 (-30.68%)
since 06/13/24

Most Recent Stories

More News
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y

Accuray Incorporated ARAY reported third-quarter fiscal 2025 loss per share of a cent compared with the year-ago period’s loss of 6 cents. The bottom line surpassed the Zacks Consensus Estimate by 80%.ARAY’s...

ARAY : 1.2200 (-2.40%)
MASI : 161.20 (-2.50%)
FMS : 28.61 (-1.14%)
AHCO : 8.60 (-2.22%)
Accuray: Fiscal Q3 Earnings Snapshot

Accuray: Fiscal Q3 Earnings Snapshot

ARAY : 1.2200 (-2.40%)
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now

Accuray Incorporated ARAY is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust global performance in the second quarter...

AVAH : 4.91 (-3.35%)
ARAY : 1.2200 (-2.40%)
MASI : 161.20 (-2.50%)
ATEC : 11.06 (-2.73%)
Accuray: Fiscal Q2 Earnings Snapshot

Accuray: Fiscal Q2 Earnings Snapshot

ARAY : 1.2200 (-2.40%)
Here's Why you Should Retain Nevro Stock in Your Portfolio Now

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its technological innovations and diversification plans regarding its product portfolio. The optimism, led by a solid third-quarter...

AXGN : 9.75 (-2.89%)
NVRO : 5.84 (unch)
ARAY : 1.2200 (-2.40%)
MASI : 161.20 (-2.50%)
Here's Why You Should Add Glaukos Stock to Your Portfolio Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial results and a robust product pipeline. However, stiff competition is a concern.Shares of this Zacks Rank #2 (Buy)...

AXGN : 9.75 (-2.89%)
ARAY : 1.2200 (-2.40%)
MASI : 161.20 (-2.50%)
GKOS : 97.60 (unch)
HealthEquity Stock Falls Despite Q3 Earnings and Revenue Beat

HealthEquity, Inc. HQY reported adjusted earnings per share (EPS) of 78 cents in third-quarter fiscal 2025, surpassing the Zacks Consensus Estimate by 9.86%. The bottom line improved 30% on a year-over-year...

AXGN : 9.75 (-2.89%)
HQY : 104.76 (+0.74%)
ARAY : 1.2200 (-2.40%)
MASI : 161.20 (-2.50%)
Here's Why You Should Add Accuray Stock in Your Portfolio Now

Accuray Incorporated ARAY is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust international performance in the first quarter...

AXGN : 9.75 (-2.89%)
ARAY : 1.2200 (-2.40%)
MASI : 161.20 (-2.50%)
ANGO : 10.66 (-2.11%)
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

DENTSPLY SIRONA XRAY is well-poised for growth due to its robust product portfolio and continued focus on research and development. However, forex remains a concern.Shares of this Zacks Rank #3 (Hold)...

AXGN : 9.75 (-2.89%)
ARAY : 1.2200 (-2.40%)
MASI : 161.20 (-2.50%)
XRAY : 15.63 (-2.37%)
Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Inari Medical, Inc. NARI is well poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency...

AXGN : 9.75 (-2.89%)
ARAY : 1.2200 (-2.40%)
MASI : 161.20 (-2.50%)
NARI : 79.97 (+0.05%)

Business Summary

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing...

See More

Key Turning Points

3rd Resistance Point 1.3000
2nd Resistance Point 1.2800
1st Resistance Point 1.2500
Last Price 1.2200
1st Support Level 1.2000
2nd Support Level 1.1800
3rd Support Level 1.1500

See More

52-Week High 2.9500
Fibonacci 61.8% 2.2586
Fibonacci 50% 2.0451
Fibonacci 38.2% 1.8315
Last Price 1.2200
52-Week Low 1.1401

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar